A Study of LY2940680 in Pediatric Medulloblastoma or Rhabdomyosarcoma

Clinical trial NCT01697514 · WITHDRAWN

Trial details

NCT number: NCT01697514
Sponsor: Eli Lilly and Company
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Medulloblastoma, Childhood Rhabdomyosarcoma

Start date: 2013-07-01
Primary completion: 2016-07-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.